Verastem, Inc.
Company Stats
- Market Cap
- $729.0M
- as of Sep 30, 2026
- Shares Outstanding
- 90.6M
- Free Float
- 92.1%
Income Statement
- Revenue
- $30.9M
- Operating Income
- -$170.1M
- Net Income
- -$209.5M
- EBITDA
- -$170.1M
- Revenue Growth, 3Y
- 128.4%
Balance Sheet
- Cash & Equivalents
- $205.0M
Returns & Capital
- SBC, 3Y Avg
- $7.5M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $30.9M | — | — |
| FY2024 | $10.0M | -$104.8M | -1048.0% |
| FY2023 | — | -$86.5M | — |
| FY2022 | $2.6M | — | — |
| FY2021 | $2.1M | -$53.7M | -2615.6% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 31, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back